GH vs TMFX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GH is a Buy and TMFX is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GH’s FA Score shows that 0 FA rating(s) are green while.
- GH’s FA Score: 0 green, 5 red.
Price Growth
GH (@Medical Specialties) experienced а +12.90% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was +5.76%. For the same industry, the average monthly price growth was +7.52%, and the average quarterly price growth was +0.65%.
Reported Earning Dates
GH is expected to report earnings on Oct 31, 2024.
Industries' Descriptions
@Medical Specialties (+5.76% weekly)Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
GH | ||
|---|---|---|
OUTLOOK RATING 1..100 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 100 | |
PRICE GROWTH RATING 1..100 | 55 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| TMFX | |
|---|---|
| RSI ODDS (%) | N/A |
| Stochastic ODDS (%) | 4 days ago 83% |
| Momentum ODDS (%) | 4 days ago 84% |
| MACD ODDS (%) | 4 days ago 90% |
| TrendWeek ODDS (%) | 4 days ago 81% |
| TrendMonth ODDS (%) | 4 days ago 82% |
| Advances ODDS (%) | 4 days ago 81% |
| Declines ODDS (%) | 11 days ago 82% |
| BollingerBands ODDS (%) | 4 days ago 90% |
| Aroon ODDS (%) | 4 days ago 84% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| OBSOX | 25.79 | 0.48 | +1.90% |
| Oberweis Small-Cap Opportunities | |||
| CNPIX | 82.51 | 0.86 | +1.05% |
| Consumer Staples UltraSector ProFund Inv | |||
| PXIIX | 21.22 | 0.20 | +0.95% |
| Virtus KAR Equity Income I | |||
| PCAOX | 79.35 | 0.45 | +0.57% |
| Principal Capital Appreciation R3 | |||
| RIGCX | 10.97 | 0.02 | +0.18% |
| Victory RS International C | |||
GH and
Correlation & Price change
A.I.dvisor indicates that over the last year, GH has been loosely correlated with VCYT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if GH jumps, then VCYT could also see price increases.
TMFX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMFX has been loosely correlated with PHIN. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if TMFX jumps, then PHIN could also see price increases.
| Ticker / NAME | Correlation To TMFX | 1D Price Change % | ||
|---|---|---|---|---|
| TMFX | 100% | +1.68% | ||
| PHIN - TMFX | 50% Loosely correlated | +1.33% | ||
| RXO - TMFX | 41% Loosely correlated | +0.59% | ||
| CAVA - TMFX | 40% Loosely correlated | -2.36% | ||
| VTS - TMFX | 36% Loosely correlated | +1.32% | ||
| GH - TMFX | 27% Poorly correlated | +4.73% | ||
More | ||||